The choline-leakage hypothesis for the loss of acetylcholine in Alzheimer's disease

Biophysical Journal

Volumn 73, Issue 3, 1997, Pages 1276-1280

  Ehrenstein, Gerald ^a,c   Galdzicki, Zygmunt ^b   Lange, G David ^a  

^a NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

^b NATIONAL INSTITUTE ON AGING   (United States)

^c NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCHOLINE; AMYLOID BETA PROTEIN; CHOLINE;

ACETYLCHOLINE BRAIN LEVEL; ALZHEIMER DISEASE; ARTICLE; CELL MEMBRANE PERMEABILITY; HUMAN; PATHOGENESIS;

EID: 0030807627     PISSN: 00063495     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-3495(97)78160-8     Document Type: Article

References (30)

1. Arispe, N., E. Rojas, and H. B. Pollard. 1993. Alzheimer disease amyloid beta protein forms calcium channels in bilayer membranes: blockade by tromethamine and aluminum. Proc. Natl. Acad. Sci. USA. 90:567-571.
2. Bartus, R. T., R. L. Dean III, B. Beer, and A. S. Lippa. 1982. The cholinergic hypothesis of geriatric memory dysfunction. Science. 217: 408-414.
3. Butterfield, D. A., M. M. Nicholas, and W. R. Markesbery. 1985. Evidence for an increased rate of choline efflux across erythrocyte membranes in Alzheimer's disease. Neurochem. Res. 10:909-918.
4. Buxbaum, J. D., A. A. Ruefli, C. A. Parker, A. M. Cypess, and P. Greengard. 1994. Calcium regulates processing of the Alzheimer amyloid protein precursor in a protein kinase C-independent manner. Proc. Natl. Acad. Sci. USA. 91:4489-93.
5. Callahan, L. M., and P. D. Coleman. 1995. Neurons bearing neurofibrillary tangles are responsible for selected synaptic deficits in Alzheimer's disease. Neurobiol. Aging. 16:311-4.
6. Castano, E. M., F. Prelli, T. Wisniewski, A. Golabek, R. A. Kumar, C. Soto, and B. Frangione. 1995. Fibrillogenesis in Alzheimer's disease of amyloid beta peptides and apolipoprotein E. Biochem J. 306(Pt 2): 599-604.
7. Davis, K. L., J. Y.-K. Hsieh, M. I. Levy, T. B. Horvath, B. M. Davis, and R. C. Mohs. 1982. Cerebrospinal fluid acetylcholine, choline, and senile dementia of the Alzheimer's type. Psychopharmacol Bull. 18:193-195.
8. Elble, R., E. Giacobini, and C. Higgins. 1989. Choline levels are increased in cerebrospinal fluid of Alzheimer patients. Neurobiol. Aging. 10: 45-50.
9. Fukuyama, R., K. C. Wadhwani, Z. Galdzicki, S. I. Rapoport, and G. Ehrenstein. 1994. β-Amyloid polypeptide increases calcium uptake in PC12 cells: a possible mechanism for its cellular toxicity in Alzheimer's disease. Brain Res. 667:269-72.
10. Galdzicki, Z., R. Fukuyama, K. C. Wadhwani, S. I. Rapoport, and G. Ehrenstein. 1994. β-Amyloid increases choline conductance of PC12 cells: possible mechanism of toxicity in Alzheimer's disease. Brain Res. 646:332-336.
11. Hardy, J. A., and G. A. Higgins. 1992. Alzheimer's disease: the amyloid cascade hypothesis. Science. 256:184-185.
12. Hung, A. Y., C. Haass, R. M. Nitsch, W. Q. Qiu, M. Citron, R. J. Wurtman, J. H. Growdon, and D. J. Selkoe. 1993. Activation of protein kinase C inhibits cellular production of the amyloid beta-protein. J. Biol. Chem. 268:22959-22962.
13. Knipper, M., M. da Penha, Berzaghi, A. Blochl, H. Breer, H. Thoenen, and D. Lindholm. 1994. Positive feedback between acetylcholine and the neurotrophins nerve growth factor and brain-derived neurotrophic factor in the rat hippocampus. Eur. J. Neurosci. 6:668-671.
14. Koliatsos, V. E., and D. L. Price. 1991. The basal forebrain cholinergic system: an evolving concept in the neurobiology of the forebrain. In Activation to Acquisition: Functional Aspects of the Basal Forebrain Cholinergic System. Birkhäuser, Boston. 11-71.
15. Lai, F., and R. S. Williams. 1989. A prospective study of Alzheimer disease in Down syndrome. Arch. Neurol. 46:849-853.
16. Mann, D. M. 1988. The pathological association between Down syndrome and Alzheimer disease. Mech. Ageing Dev. 43:99-136.
17. Nitsch, R. M., J. K. Blusztajn, A. G. Pittas, B. E. Slack, J. H. Growdon, and R. J. Wurtman. 1992. Evidence for a membrane defect in Alzheimer disease brain. Proc. Natl. Acad. Sci. USA. 89:1671-1675.
18. Rumble, B., R. Retallack, C. Hilbich, G. Simms, G. Multhaup, R. Martins, A. Hockey, P. Montgomery, K. Beyreuther, and C. L. Masters. 1989. Amyloid A4 protein and its precursor in Down's syndrome and Alzheimer's disease. N. Engl. J. Med. 320:1446-1452 (see comments).
19. Schwartz, J. P. 1992. Neurotransmitters as neurotrophic factors: a new set of functions. Int. Rev. Neurobiol. 34:1-23.
20. Slotkin, T. A., C. B. Nemeroff, G. Bissette, and F. J. Seidler. 1994. Overexpression of the high affinity choline transporter in cortical regions affected by Alzheimer's disease. Evidence from rapid autopsy studies. J. Clin. Invest. 94:696-702 (see comments).
21. Slotkin, T. A., F. J. Seidler, B. J. Crain, J. M. Bell, G. Bissette, and C. B. Nemeroff. 1990. Regulatory changes in presynaptic cholinergic function assessed in rapid autopsy material from patients with Alzheimer disease: implications for etiology and therapy. Proc. Natl. Acad. Sci. USA. 87:2452-2455.
22. Strittmatter, W. J., A. M. Saunders, D. Schmechel, V. M. Pericak, J. Enghild, G. S. Salvesen, and A. D. Roses. 1993. Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease. Proc. Natl. Acad. Sci. USA. 90:1977-1981.
23. Tohgi, H., T. Abe, K. Hashiguchi, M. Saheki, and S. Takahashi. 1994. Remarkable reduction in acetylcholine concentration in the cerebrospinal fluid from patients with Alzheimer type dementia. Neurosci. Lett. 177:139-142.
24. Tucek, S. 1985. Regulation of acetylcholine synthesis in the brain. J. Neurochem. 44:11-24.
25. Wallace, W., S. T. Ahlers, J. Gotlib, V. Bragin, J. Sugar, R. Gluck, P. A. Shea, K. L. Davis, and V. Haroutunian. 1993. Amyloid precursor protein in the cerebral cortex is rapidly and persistently induced by loss of subcortical innervation. Proc. Natl. Acad. Sci. USA. 90:8712-8716.
26. Winblad, B., E. Messamore, C. O'Neill, and R. Cowburn. 1993. Biochemical pathology and treatment strategies in Alzheimer's disease: emphasis on the cholinergic system. Acta Neurol. Scand. Suppl. 149:4-6.
27. Wisniewski, K. E., H. M. Wisniewski, and G. Y. Wen. 1985. Occurrence of neuropathological changes and dementia of Alzheimer's disease in Down's syndrome. Ann. Neurol. 17:278-282.
28. Wurtman, R. J. 1992. Choline metabolism as a basis for the selective vulnerability of cholinergic neurons. Trends Neurosci. 15:117-122.
29. Wurtman, R. J. 1994. The return of the cholinergic hypothesis. J. Clin. Invest. 94:470 (editorial, comment).
30. Yankner, B. A., L. K. Duffy, and D. A. Kirschner. 1990. Neurotrophic and neurotoxic effects of amyloid beta protein: reversal by tachykinin neuropeptides. Science. 250:279-282.